If the pharmaceutical companies can prove their shots do not harm or kill anyone then why are they not offering the proof?This is faulty logic that I am firmly convinced at this point is entirely intentional.
Because natural immunity is more effective than the vaccine, doesn't mean that the vaccine is ineffective, which Marke here is clearly implying.
The Pfizer vaccine is about 90% effective in preventing symptomatic COVID19 (i.e. that number includes all known variants). In fact, the vaccines probably are affording the public herd immunity at this point against everything COVID except the Delta variant which accounts for something like 98-99% of new cases in the United States and England. All the other variants are all but gone - thanks to the Phizer, Moderna and Johson and Johnson vaccines as well as natural immunity. The vast majority of new cases are people who did not get the vaccine. 99.5% of all those who have died of COVID since January have been unvaccinated.
According to an analysis carried out by Public Health England, two doses of the Pfizer-BioNTech vaccine appeared to be about 88 percent effective against symptomatic disease and 96 percent effective against hospitalization with the Delta variant.The same study suggested that the vaccine was approximately 80 percent effective against preventing infection from the Delta variant. Scientists came to this conclusion after analyzing 14,019 people with an infection, 166 of whom were hospitalized, in England.Vaccines had a protective effect against infections with Delta and hospital cases were milder, the study found.Public Health England also shared real-world data in May that solidified the importance of having a second dose of COVID-19 vaccine. The analysis suggested that a single dose of the Pfizer-BioNTech vaccine offered only about 33 percent protection against symptomatic disease.This was a reduction from the previous 50 percent effectiveness estimated against the alpha variant.The study also found that the Pfizer-BioNTech vaccine was 88 percent effective against the Delta variant 2 weeks after the second dose.